Cellular membrane phospholipids and systemic lipid metabolic pathways

Cellular membrane phospholipids and systemic lipid metabolic pathways refers to the integrated network of molecules and biochemical reactions responsible for maintaining lipid balance within the body. Phospholipids, such as phosphatidylcholine and phosphatidylethanolamine, are essential for the formation of the lipid bilayer, which provides structural integrity to cells and serves as a platform for membrane-bound proteins [Nature Reviews Molecular Cell Biology, 2008]. Systemic lipid metabolism involves the coordinated synthesis, transport, and degradation of cholesterol, triglycerides, and fatty acids, primarily regulated by the liver and adipose tissue [Comprehensive Physiology, 2017]. Dysregulation of these pathways is a primary driver of metabolic and cardiovascular diseases, including atherosclerosis and nonalcoholic fatty liver disease [Journal of Clinical Investigation, 2001]. While this entry represents a broad physiological system rather than a single protein target, many drugs interact with specific enzymes or transporters within these pathways to manage lipid levels [Journal of the American College of Cardiology, 2019]. For example, statins inhibit HMG-CoA reductase to reduce cholesterol synthesis, while PCSK9 inhibitors enhance the clearance of low-density lipoproteins from the blood [JAMA Cardiology, 2019].

Other names

Lipid metabolismLipid homeostasisPhospholipid metabolismMembrane lipid pathways

Modulation of lipid synthesis, absorption, and clearance through the inhibition of specific enzymes (e.g., HMG-CoA reductase) or transporters (e.g., NPC1L1) and the regulation of lipoprotein receptor expression [Journal of the American College of Cardiology, 2019; JAMA Cardiology, 2019].